Abstract
Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) is now considered as a perfect complement to HPLC-DAD (diode array detection) and gas chromatography (GC)-MS for the general unknown screening of drugs and toxic compounds.
Here we describe a procedure applied routinely in our laboratory for clinical and forensic applications using the QTRAP™ technology.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Saint-Marcoux F, Sauvage FL, Marquet P (2007) Current role of LC-MS in therapeutic drug monitoring. Anal Bioanal Chem 388:1327–1349
Marquet P (2002) Is LC-MS suitable for a comprehensive screening of drugs and poisons in clinical toxicology? Ther Drug Monit 24:125–133
Marquet P (2002) Progress of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Ther Drug Monit 24:255–276
Maurer HH (2005) Multi-analyte procedures for screening for and quantification of drugs in blood, plasma; or serum by liquid chromatography-single stage or tandem mass spectrometry (LC-MS or LC-MS/MS) relevant to clinical and forensic toxicology. Clin Biochem 38:310–318
Maurer HH (2007) Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal Bioanal Chem 388:1315–1325
Maurer HH (2010) Perspectives of liquid chromatography coupled to low- and high resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology. Ther Drug Monit 32:324–327
Gergov M, Ojanperä I, Vuori E (2003) Simultaneous screening for 238 drugs by liquid chromatography-ion spray tandem mass spectrometry with multiple-reaction monitoring. J Chromatogr B Analyt Technol Biomed Life Sci 795:41–53
Sauvage FL, Gaulier JM, Lachâtre G, Marquet P (2008) Pitfalls and prevention strategies for liquid chromatography–tandem mass spectrometry in the selected-reaction monitoring mode for drug analysis. Clin Chem 54:1519–1527
Peters FT, Drummer OH, Musshoff O (2007) Validation of new methods. Forensic Sci Int 165:216–224
Hager JW, Le Blanc JC (2003) High performance liquid chromatography–tandem mass spectrometry with a new quadrupole/linear ion trap instrument. J Chromatogr A 1020:3–9
Sauvage FL, Saint-Marcoux F, Duretz B, Deporte D, Lachâtre G, Marquet P (2006) Screening of drugs and toxic compounds with liquid chromatography-linear ion trap tandem mass spectrometry. Clin Chem 52:1732–1742
Picard N, Dridi D, Sauvage FL, Boughattas NA, Marquet P (2009) General unknown screening procedure for the characterization of human drug metabolites. Application to loratadine phase I metabolism. J Sep Sci 32:2209–2217
Sauvage FL, Picard N, Saint-Marcoux F, Gaulier JM, Lachâtre G, Marquet P (2009) General unknown screening procedure for the characterization of human drug metabolites in forensic toxicology. Applications and constraints. J Sep Sci 32:3074–3083
Mueller CA, Weinmann W, Dresen S, Schreiber A, Gergov M (2005) Development of a multi-target screening analysis for 301 drugs using a QTrap liquid chromatography/tandem mass spectrometry system and automated library searching. Rapid Commun Mass Spectrom 19:1332–1338
Dresen S, Ferreiros N, Gnann H, Zimmermann R, Weinmann W (2010) Detection and identification of 700 drugs by multi-target screening with a 3200QTRAP LC-MS/MS system and library searching. Anal Bioanal Chem 396:2425–2434
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Sauvage, FL., Marquet, P. (2012). LC-MS/MS Screen for Xenobiotics and Metabolites. In: Langman, L., Snozek, C. (eds) LC-MS in Drug Analysis. Methods in Molecular Biology, vol 902. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-934-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-61779-934-1_11
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61779-933-4
Online ISBN: 978-1-61779-934-1
eBook Packages: Springer Protocols